Literature DB >> 16155429

Autonomic impairment in amyotrophic lateral sclerosis.

Rositsa Baltadzhieva1, Tanya Gurevich, Amos D Korczyn.   

Abstract

PURPOSE OF REVIEW: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by progressive loss of motor neurones, but it is increasingly recognized to be a more disseminated disease. The autonomic nervous system may also be involved. Here we review the literature with specific emphasis on autonomic functions in ALS. RECENT STUDIES: Ample evidence exists for subclinical dysfunction of cardiovascular, sudomotor, gastrointestinal, salivary and lacrimal regulation, even in early ALS cases. Autonomic disturbances may lead to circulatory collapse or sudden death in respirator dependent patients. Several studies suggest the existence of sympathetic hyperactivity in ALS. We discuss some possible pathophysiological mechanisms of the subtle abnormalities and some clinical and treatment implications.
SUMMARY: The wide range of autonomic involvement, together with results suggesting cognitive and extrapyramidal dysfunction, supports the view that ALS is a multisystem degenerative disease.

Entities:  

Mesh:

Year:  2005        PMID: 16155429     DOI: 10.1097/01.wco.0000183114.76056.0e

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  29 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

2.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

Review 3.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

4.  Cutaneous somatic and autonomic nerve TDP-43 deposition in amyotrophic lateral sclerosis.

Authors:  Yuting Ren; Wenxiu Liu; Yifan Li; Bo Sun; Yanran Li; Fei Yang; Hongfen Wang; Mao Li; Fang Cui; Xusheng Huang
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

5.  Effects of Intraoperative Vagal Nerve Stimulation on the Gastrointestinal Microbiome in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Megan M Haney; Aaron C Ericsson; Teresa E Lever
Journal:  Comp Med       Date:  2018-11-13       Impact factor: 0.982

Review 6.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

Review 7.  Motor neuron disease of paraneoplastic origin: a rare but treatable condition.

Authors:  Nicolas Mélé; Giulia Berzero; Thierry Maisonobe; François Salachas; Guillaume Nicolas; Nicolas Weiss; Guillemette Beaudonnet; Francois Ducray; Dimitri Psimaras; Timothée Lenglet
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

8.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

9.  Thalidomide causes sinus bradycardia in ALS.

Authors:  Thomas Meyer; André Maier; Nadja Borisow; Jörn S Dullinger; Gerald Splettstösser; Stephanie Ohlraun; Christoph Münch; Peter Linke
Journal:  J Neurol       Date:  2008-04-21       Impact factor: 4.849

10.  Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutation.

Authors:  Li Di; Hai Chen; Yuwei Da; Suobing Wang; Xin-Ming Shen
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.